Abstract
Radiation therapy using radioactive materials within the patient, i.e., permanently implanted sealed brachytherapy seeds and unsealed targeted radiopharmaceuticals, is routinely used to treat cancer patients. Radioactive patients may safely be released from radiation safety restrictions when the most exposed person is unlikely to receive more than 5 mSv (500 mrem) according to the United States Nuclear Regulatory Commission. NUREG 1556 Volume 9 Appendix U Revision 2 presents regulatory guidance that may be used to assure compliance with this limit. This risk‐based approach is a big step forward from the prior activity‐based release criteria. This session will introduce commonly used radiation therapies using internal sealed and unsealed radioactive sources and discuss the criteria and computational methods for the safe release of radioactive patients. Essential components of NRC Part 35 Medical Use of Byproduct Material will also be presented.Learning Objectives:1. Introduce commonly used radiation therapies involving internally administered radioactive materials2. Present NRC guidelines and perform the calculations in the regulatory guidance documents3. Understand the implications and limitation of the release criteria calculation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.